BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29454364)

  • 1. Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy.
    Leruez S; Verny C; Bonneau D; Procaccio V; Lenaers G; Amati-Bonneau P; Reynier P; Scherer C; Prundean A; Orssaud C; Zanlonghi X; Rougier MB; Tilikete C; Miléa D
    Orphanet J Rare Dis; 2018 Feb; 13(1):33. PubMed ID: 29454364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber's hereditary optic neuropathy.
    Ahn YJ; Park Y; Shin SY; Chae H; Kim M; Park SH
    Graefes Arch Clin Exp Ophthalmol; 2020 Oct; 258(10):2283-2290. PubMed ID: 32506279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.
    Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B
    EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
    Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
    Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
    Pemp B; Kircher K; Reitner A
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.
    Newman NJ; Biousse V; David R; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Newman SA; Turbin RE; Chen K; Keaney RP
    Am J Ophthalmol; 2005 Sep; 140(3):407-15. PubMed ID: 16083844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Observation of Patients with Leber's Hereditary Optic Neuropathy Before Gene Therapy.
    Yuan J; Zhang Y; Liu H; Tian Z; Li X; Zheng Y; Gao Q; Song L; Xiao X; Sun J; Wang Z; Li B
    Curr Gene Ther; 2018; 18(6):386-392. PubMed ID: 30394208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Raxone in the Leber optical neuropathy: Parisian experience].
    Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
    J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leber's Hereditary Optic Neuropathy - Case Discussion.
    Culea C; Tăbăcaru B; Stanca S; Stanca HT
    Rom J Ophthalmol; 2019; 63(1):91-101. PubMed ID: 31198903
    [No Abstract]   [Full Text] [Related]  

  • 10. Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
    Hsu TK; Wang AG; Yen MY; Liu JH
    Clin Exp Optom; 2014 Jan; 97(1):84-6. PubMed ID: 23905692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Past, present, and future in Leber's hereditary optic neuropathy].
    Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):809-27. PubMed ID: 11802455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
    Chan JW; Sultan W; Karanjia R; Sadun AA
    Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History of Conversion of Leber's Hereditary Optic Neuropathy: A Prospective Case Series.
    Hwang TJ; Karanjia R; Moraes-Filho MN; Gale J; Tran JS; Chu ER; Salomao SR; Berezovsky A; Belfort R; Moraes MN; Sadun F; DeNegri AM; La Morgia C; Barboni P; Ramos CDVF; Chicani CF; Quiros PA; Carelli V; Sadun AA
    Ophthalmology; 2017 Jun; 124(6):843-850. PubMed ID: 28196731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
    Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
    Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular thickness changes in a patient with Leber's hereditary optic neuropathy.
    Mizoguchi A; Hashimoto Y; Shinmei Y; Nozaki M; Ishijima K; Tagawa Y; Ishida S
    BMC Ophthalmol; 2015 Mar; 15():27. PubMed ID: 25885098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolomic signature of Leber's hereditary optic neuropathy reveals endoplasmic reticulum stress.
    Chao de la Barca JM; Simard G; Amati-Bonneau P; Safiedeen Z; Prunier-Mirebeau D; Chupin S; Gadras C; Tessier L; Gueguen N; Chevrollier A; Desquiret-Dumas V; Ferré M; Bris C; Kouassi Nzoughet J; Bocca C; Leruez S; Verny C; Miléa D; Bonneau D; Lenaers G; Martinez MC; Procaccio V; Reynier P
    Brain; 2016 Nov; 139(11):2864-2876. PubMed ID: 27633772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of optic nerve in patients with Leber's hereditary optic neuropathy using reduced field-of-view diffusion tensor imaging.
    Wang L; Fan K; Zhang Y; Chen Y; Tian Q; Shi D
    Eur J Radiol; 2017 Aug; 93():24-29. PubMed ID: 28668421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy.
    Ziccardi L; Sadun F; De Negri AM; Barboni P; Savini G; Borrelli E; La Morgia C; Carelli V; Parisi V
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6893-901. PubMed ID: 24071953
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.